Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.42%
Variazione Mensile
-11.86%
Variazione di 6 mesi
-38.49%
Variazione Annuale
+6.32%
Chiusura Precedente
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Mercati
Mercato Azionario Statunitense
Salute
VSTM
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
44.51 M
51.49 M
54.95 M
61.55 M
66.78 M
—
Valuation ratios
Enterprise value
19.9 M
177.37 M
213.77 M
91.09 M
451.93 M
934.16 M
Price to earnings ratio
—
-1.41
-1.79
-1.13
-2
-6.34
Price to sales ratio
8.03
18.46
14.85
63.8
36.92
134.03
Price to cash flow ratio
0.71
1.76
1.88
1.56
3.59
8.8
Price to book ratio
0.65
-6.39
-17.08
-7.89
-7.89
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.19
0.64
0.4
0.13
0.56
1.72
Return on equity %
2.17
2.23
1.61
0.72
6.35
10.91
Return on invested capital %
1 018.92
1 043.91
2 007.91
967.24
602.43
4 621.49
Gross margin %
—
—
100
94.01
97.33
—
Operating margin %
—
—
2 419.17
2 047.92
362.17
—
EBITDA margin %
—
—
—
-2 027.09
-344.72
—
Net margin %
—
—
2 853.4
1 213.57
876.34
—
Liquidity ratios
Quick ratio
—
—
—
3.44
2.55
—
Current ratio
3.23
3.07
3.5
3.46
2.58
12.61
Inventory turnover
—
—
—
0.03
0.2
—
Asset turnover
0
0
0.02
0.01
0.06
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.4
0.54
0.38
0.44
1.76
Long term debt to total equity ratio
2.77
1.41
2.2
2.06
5.03
10.71
Per share metrics
Operating cash flow per share
0.59
0.7
0.71
0.44
0.5
2.35
EBIT per share
—
—
—
-0.59
-0.54
—
EBITDA per share
—
—
—
-0.59
-0.53
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.81
2.49
2.17
2.22
1.88
8.76
Net current asset value per share
3
2.66
2.3
2.35
2.11
9.42
Tangible book value per share
0.27
0.81
0.6
0.28
-0.02
1.67
Working capital per share
2.07
1.79
1.64
1.67
1.29
6.4
Book value per share
0.27
0.81
0.6
0.49
0.21
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Notizie
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley riconferma il rating Buy per le azioni Verastem, mantiene target a $16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem riporta 17,5 milioni di dollari di ricavi nel Q4 per trattamento oncologico
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Il titolo di Revolution Medicines balza oltre il 20% su possibile acquisizione AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Azioni Verastem stabili mentre Mizuho riconferma rating Outperform